Plasma levels and urinary excretion of amino acids by subjects with renal calculi
- PMID: 19787430
- DOI: 10.1007/s00726-009-0359-z
Plasma levels and urinary excretion of amino acids by subjects with renal calculi
Abstract
Plasma levels and urinary amino acid excretions were estimated by high-performance liquid chromatography in 15 control subjects and 36 stone formers (SFs) classified according to the stone type: (1) 22 cases with calcium oxalate stones; (2) four cases with pure uric acid stones; (3) 10 cases with magnesium-ammonium phosphate stones, either pure or mixed with apatite. Some types of stones (namely oxalate and uric acid calculi) are mainly formed as a result of a metabolic deficiency that may affect the amino acid metabolism, and thus may be reflected in the urinary amino acid pattern. Data demonstrated clearly that there is a general tendency towards decreased amino acid excretions in all SFs with all types of stones. As a whole, one can observe a higher percentage of patients with calcium oxalate and phosphate calculosis, who have low urine excretions of amino acids; about 50% are the SFs with lower urine excretion of serine, glycine, taurine and i-leucine; the high percentage of patients with CaOX calculi shows lower urine excretions of tyrosine and ornithine.
Similar articles
-
Effect of pH on the microhardness of renal calculi.J Biomed Mater Res. 1986 Sep;20(7):945-50. doi: 10.1002/jbm.820200709. J Biomed Mater Res. 1986. PMID: 3760010
-
Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.Eur J Med Res. 2009 Sep 1;14(9):378-92. doi: 10.1186/2047-783x-14-9-378. Eur J Med Res. 2009. PMID: 19748857 Free PMC article.
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
-
Spectrum of stone composition: structural analysis of 1050 upper urinary tract calculi from northern India.Int J Urol. 2005 Jan;12(1):12-6. doi: 10.1111/j.1442-2042.2004.00990.x. Int J Urol. 2005. PMID: 15661049
-
Kidney stone disease.J Clin Invest. 2005 Oct;115(10):2598-608. doi: 10.1172/JCI26662. J Clin Invest. 2005. PMID: 16200192 Free PMC article. Review.
Cited by
-
Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease.Sci Rep. 2018 Nov 9;8(1):16598. doi: 10.1038/s41598-018-33773-5. Sci Rep. 2018. PMID: 30413731 Free PMC article.
-
Lack of evidence for the association of ornithine decarboxylase (+316 G>A), spermidine/spermine acetyl transferase (-1415 T>C) gene polymorphisms with calcium oxalate stone disease.Biomed Rep. 2014 Jan;2(1):69-74. doi: 10.3892/br.2013.184. Epub 2013 Oct 21. Biomed Rep. 2014. PMID: 24649071 Free PMC article.
-
Nonsteroidal anti-inflammatory drugs, blood metabolites, and kidney stones: a comprehensive Mendelian randomization study.Urolithiasis. 2025 Apr 24;53(1):77. doi: 10.1007/s00240-025-01749-6. Urolithiasis. 2025. PMID: 40274636
-
A Specific Urinary Amino Acid Profile Characterizes People with Kidney Stones.Dis Markers. 2020 Jun 30;2020:8848225. doi: 10.1155/2020/8848225. eCollection 2020. Dis Markers. 2020. PMID: 32670436 Free PMC article.
-
Anti-Gout Effects of the Medicinal Fungus Phellinus igniarius in Hyperuricaemia and Acute Gouty Arthritis Rat Models.Front Pharmacol. 2022 Jan 11;12:801910. doi: 10.3389/fphar.2021.801910. eCollection 2021. Front Pharmacol. 2022. PMID: 35087407 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials